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Introduction 
The FVB/N  mouse strain is one of the most 
commonly used for the generation of transgenic 
mouse models, mainly due to its defined inbred 
background, high reproductive capacity and the 
large dimensions of pronuclei which facilitate the 
microinjection of genetic material (Taketo et al. 
1991). However, with the increasing number of 
studies that characterized the behaviour, pathology 
and anatomy of transgenic mouse models, several 
pieces of evidence started to emerge that raised 
doubts upon the appropriateness of using this strain 
for behavioural studies. For instance the FVB/N 
mouse strain carries the rd mutation (for retinal 
degeneration) leading to visual impairment that 
was shown to result in a low performance in spatial 
and non-spatial cognitive tasks (Royle et al. 1999; 
Voikar et al. 2001; Nguyen & Gerlai 2002; Pugh 
et al. 2004). In addition, a behavioural comparison 
between the FVB/N and C57Bl/6 strains using four 
different tests revealed that FVB/N animals display 
increased anxiety-like behaviour, aggression, 
hyperactivity and impairment in learning in the 
Morris water maze paradigm (Mineur & Crusio 
2002). 
The FVB/N strain was also described as being 
susceptible to epilepsy. In a sample of transgenic 
and non-transgenic FVB/N mice with a mean age 
of 5.8 months in which induced or spontaneous 
generalized seizures had been observed, the brains 
of affected animals were shown to display neuronal 
loss and concomitant astrocyte hypertrophy in the 
cerebral cortex, hippocampus and thalamus (Goelz 
et al. 1998). The pattern of ischemic neuronal 
necrosis observed was consistent with the type of 
lesions associated with status epilepticus in humans. 
In another study, FVB/N mice after administration 
of kainic acid demonstrated a more severe seizure 
response and mortality rate (62%) than the 129/
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Summary
The FVB/N mouse strain (Mus musculus) is often used for generation of transgenic animals. However, it 
has also been the object of several studies in epilepsy research due to its increased susceptibility to develop 
spontaneous and induced seizures and its sensitivity to seizure-triggered neuronal death.
We aimed to analyse behavioural changes observed in FVB/N mice that had seizure episodes throughout 
life. For this, we assessed the behaviour profile of 52-week old FVB/N animals displaying repeated 
spontaneous seizures, using the SHIRPA protocol. These epileptic mice also displayed a marked gait ataxia 
and decreased locomotor and exploratory activity. Moreover, these animals weighed less than control mice, 
and displayed increased signs of aggression and vocalization behaviours. Analysis of the data by clusters 
showed that in the epileptic mice there were significant deficits in the SHIRPA “spinocerebellar function”, 
“neuropsychiatric function” and “muscle and lower motor neuron function” scores, suggesting extensive 
brain damage caused by repeated experience of seizures.  
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Ola,  BALB/c and C56BL/6 mouse strains (Royle 
et al. 1999). Although the greater susceptibility 
to develop seizures was not confirmed in two 
other studies (Schauwecker et al. 2004; McLin & 
Steward 2006), the increased vulnerability of the 
FVB/N strain to seizure-induced brain damage 
was confirmed histopathologically in all studies 
by a greater degree of cell loss in the hippocampus 
(Royle et al. 1999; Schauwecker et al. 2004) and 
a synaptophysin immunoreactivity decrease in the 
CA3 pyramidal cell layer (Royle et al. 1999).
The study by McLin and colleagues (2006) further 
confirmed the susceptibility of FVB/N animals to 
neuronal damage resulting from kainate-triggered 
seizures, extending these findings to many brain 
regions, such as the neocortex, striatum, thalamus, 
hypothalamus and amygdala. The hippocampal 
neurons of FVB/N mice were also shown to be 
more susceptible to cell death as a consequence 
of pilocarpine-induced seizures (a model for 
temporal lobe epilepsy); this was paralleled by the 
severity of the seizures as well as the associated 
behavioural changes (Mohajeri et al. 2004). Taken 
together these data demonstrate that the FVB/N 
strain is more sensitive to the brain excitotoxicity 
and neurodegeneration resulting from substance-
induced and spontaneous seizures. 
In a genome-wide search for quantitative trait 
loci (QTLs) affecting individual susceptibility 
to seizure-induced excitotoxic neuronal damage, 
Schauwecker et al. 2004, assessing the back-cross 
(N2) progeny of the C57BL/6 and FVB/N inbred 
mouse strains, identified a locus on the distal part 
of chromosome 18 as having the strongest and most 
significant effect upon this susceptibility. Within 
this 11cm region GalR1, Atp9b, and Nfatc1 were 
identified as interesting candidate genes for the loci 
affecting kainate-induced cell death. 
With the goal of characterizing behavioural changes 
associated with persistent epilepsy in the mouse, we 
compared the behaviour of FVB/N mice suffering 
spontaneous seizures with that of their unaffected 
littermates using the SHIRPA protocol. Our results 
demonstrate that FVB/N animals with persistent 
epilepsy present severe alterations in neurological 
function, which may result from neuropathlogical 
damage in several brain regions previously unknown 
to be implicated in this model.
Materials and Methods
Animals 
FVB/N mice were obtained from Eurogentec and 
bred to create the study group (n = 42). The mice 
were housed in type II or type III cages by gender 
(2-7 animals per cage) under a 12:12 h light-dark 
cycle with food and water available ad libitum. The 
research protocol followed the guidelines of the 
European Council Directive (86/609/EEC).  
As part of a parallel research project (animals 
were the non-transgenic controls in a study of a 
transgenic animal model for a neurological disease), 
animals were periodically observed at different ages 
by a single individual. At each age, observation 
was performed for approximately one hour, for five 
consecutive days. 
During these behavioural tests or by occasional 
observation in their home cages, approximately 
17% of animals were observed to undergo seizures; 
these were included in the current study as the 
epileptic group (females: n=3; males: n=4) whereas 
the other animals were included as the control group 
(females: n=16; males: n=19). The behavioural 
tests were performed only on animals that did not 
manifest seizures at that particular moment; a post-
ictal recovery time was always allowed.
The convulsion episodes that were observed in these 
animals were classified as generalised tonic-clonic 
seizures (Movie – supplemental data). At 52 weeks 
of age all animals were evaluated using the SHIRPA 
protocol. Behavioural tests were performed during 
the light period. After each mouse had finished a 
test, the material and the equipment was cleaned 
with a 70% ethanol solution and dried with paper 
towelling, to avoid interference with the behaviour 
of other animals.
SHIRPA protocol
We established a protocol for phenotypic 
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neurobehavioral assessment based on the primary 
screen of the SHIRPA protocol, which mimics the 
diagnostic process of general neurological and 
psychiatric examination in humans (Rogers et al. 
1997). Each mouse was placed in a viewing jar 
(15 cm diameter) for 5 min, transferred to an arena 
(55 x 33 x 18 cm) and then a series of anatomical 
and neurological measures were determined. Full 
details of the SHIRPA protocol are available on 
the site: http://www.mgu.har.mrc.ac.uk/facilities/
mutagenesis/mutabase/shirpa_summary.html
In addition, we included the vertical pole test 
(Wallace et al. 1980), the footprint pattern test 
(Carter et al. 1999) and the counting of rears 
during the 5 min in the viewing jar as a measure 
of exploratory/spontaneous activity. The protocol 
was adjusted in order to minimize animal handling 
and to generate uniformity in waiting times between 
tests (Rafael et al. 2000). 
Vertical pole test
This test was performed on a wooden pole of  2 cm 
diameter approximately and 40 cm long, wrapped 
with cloth tape for improved traction. The mouse 
was placed in the center of the pole, which was held 
in a horizontal position. Then the pole was gradually 
lifted to a vertical position. Latency to fall off the 
pole was recorded with a maximum time of 1 min.
Footprinting pattern test
The footprint test was used to compare the gait 
of epileptic and control FVB/N mice. To obtain 
footprints, the hind- and forefeet of the mice 
were coated with black and red non-toxic paints, 
respectively. A clean sheet was placed on the floor 
of the runway for each run. The animals were then 
allowed to walk along a ramp 100 cm long, and 
4.2cm wide (with 10 cm high walls) into an enclosed 
box. Each animal was allowed to achieve one valid 
trial. The footprint patterns were analyzed for two 
step parameters (all measured in centimeters): the 
front- and hind-base width. For each step parameter, 
three values were measured for 3 consecutive steps, 
with the exclusion of the first four steps to allow 
animal habituation. 
Statistical analysis
Behavioural data were subjected to the non-
parametric Mann-Whitney U-test when variables 
were non-continuous or when a continuous variable 
did not present a normal distribution (Kolmogorov-
Smirnov test p<0.05). Continuous variables with 
normal distribution (K-S test p>0.05) were analyzed 
with the Student t-test. When differences were not 
observed between genders of each group, data 
from males and females were pooled, and statistical 
comparisons were performed using the total sample. 
Statistical analysis of the footprinting test took into 
account missing data because some animals did not 
achieve a valid trial. All statistical analyses were 
performed using SPSS 14.0 and a critical value for 
significance of p< 0.05 was used throughout the 
study.
Results 
SHIRPA protocol
The primary SHIRPA screen provides a 
comprehensive assessment of basic neurological 
and physical characteristics of mice (Rogers et al. 
1997). In this study, it allowed the identification and 
quantification of significant motor and behavioural 
abnormalities associated with established 
spontaneous epilepsy in the FVB/N genetic 
background. 
In general, epileptic animals showed decreased 
body weight (females p< 0.01; males p=0.019) (Fig 
1A), decreased spontaneous locomotor activity in 
the arena (number of squares entered by all four 
feet in 30 seconds) (p<0.01) (Fig. 1B), decreased 
number of rears (p< 0.01) (Fig. 1C) and decreased 
spontaneous activity in the viewing jar (p<0.01) 
(Table 1) and an increased number of urination 
occurrences (p< 0.01) (Fig. 1D). 
Affected FVB/N mice also presented a reduced tail 
(p<0.01) and pelvic elevation (p<0.01) (Fig. 2B), 
abnormal gait (p<0.01) and body position (p<0.01), 
palpebra closure (p<0.01) and piloerection (p<0.01). 
Neurological symptoms, such as limb grasping 
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(p<0.05), limb clasping (p<0.05), tremors (p<0.01) 
and trunk curling (p<0.01) were more frequent in 
epileptic FVB/N mice than in the controls (Fig. 2A). 
These animals also presented a higher hindlimb 
tonus (p<0.01), a deficit in the negative geotaxis 
reflex (p<0.01) and in the touch escape response 
(p<0.01). A decrease in the performance in the wire 
manoeuvre test was detected in epileptic males 
only (p< 0.01). Footprinting analysis confirmed 
that epileptic animals presented marked gait 
impairments, including a significant enlargement of 
the frontbase and hindbase width (Fig 2C-E). 
Interestingly, increased signs of aggression (p<0.05) 
and vocalization behaviours (p<0.05) were observed 
in epileptic animals during the manipulation period 
in the SHIRPA protocol (Table).
For the other parameters assessed in the SHIRPA 
protocol we did not find statistical significant 
differences, except for an increase in time spent 
holding in the vertical pole test by epileptic females 
(n=3) when compared to normal females (n=16) 
(data not shown), the significance of which is 
unclear to us.
Analysis of the SHIRPA data by clusters (Rogers 
et al. 1997) was performed to evaluate specific 
functional profiles in control and affected animals. 
Statistically significant differences (p<0.01) between 
epileptic and non-epileptic groups were detected for 
(i) spinocerebellar function; (ii) neuropsychiatric 
function; and (iii) muscle and lower motor neuron 
function (Figure 3).
Discussion
The detailed characterization of animal models of 
seizure susceptibility and reactivity has given an 
essential contribution to our understanding of the 
physiological and behavioural changes associated 
with human epilepsy (Stables et al. 2002; Stables et 
al. 2003). Many of these models require induction 
of epilepsy through administration of a substance 
such as kainic acid or pilocarpine. The present study 
provides an analysis of a spontaneous phenotype 
of seizures in an inbred mouse strain, FVB/N; the 
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Figure 1. Behavioural data showing differences 
between epileptic and control FVB/N mice in (A) 
weight, (B) locomotor activity, (C) number of rears, 
and (D) urination index. Bars indicate means ± 
SEM of each group. Asterisks indicate statistically 
significant differences in the performance of normal 
and epilepsy animals (* p<0. 05; ** p<0. 01).
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advantage of this type of study is that it avoids any 
direct effects of the drugs that may add to the effects 
of the seizures, thus confounding the analysis in 
the induced models. Our results demonstrate that 
animals with persistent epilepsy display important 
correlated behaviour abnormalities, detectable 
in several of the tasks included in the SHIRPA 
protocol.
The main limitation of our approach is that, as 
seizures in our animals were not continuously 
recorded, we cannot completely exclude the 
possibility that the control group also included 
affected animals. However, the differences 
obtained for the different behavioural tests were 
highly statistically significant, suggesting that this 
hypothetical interference in the control group might 
be very limited , if present at all.. 
FVB/N animals with recurrent epilepsy weighed 
less than control mice at 52 weeks of age. The 
decreased body weight of epileptic mice and the 
presence of piloerection might be the result of 
general morbidity, as previously described in these 
animals (Goelz et al. 1998). In addition, epilepsy-
experienced animals presented an increase in the 
number of urination occurrences (micturition), 
which has also been described in other animal 
models of epilepsy (Midzyanovskaya et al. 2005) 
and in human patients (Nowak et al. 1985).
The epileptic FVB/N animals also showed an 
increase of aggression and vocalization during 
the manipulation period in the SHIRPA protocol. 
Increased aggressive behaviour has also been 
described in humans in association with some types 
of epilepsy (Haller & Kruk 2006); this could be 
explained by dysfunction of aggression-controlling 
regions such as the downward stimulatory stream 
that includes the medial amygdala,  hypothalamic 
attack area, periaqueductal grey and locus 
coeruleus, but also forebrain cortical structures 
(Halasz et al. 2002). Recent studies on mouse 
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Table 1. Summary of SHIRPA scores that differed between control and epileptic FVB/N animals. Median 
(quartile ranges) are represented for each group and the p value of Mann-Whitney U-test is shown.
 
Shirpa scores
Body position 4.00 (1.00) 3.00 (1.00) p<0,01
Spontaneous activity 2.00 (3.00) 1.00 (1.00) p<0,01
Tremors 0.00 (1.00) 1.00 (1.00) p<0,01
Palpebra closure 0.00 (1.00) 1.00 (1.00) p<0,01
Piloerection 0.00 (1.00) 1.00 (1.00) p<0,01
Gait 0.00 (2.00) 1.00 (1.00) p<0,01
Pelvic elevation 2.00 (2.00) 1.00 (2.00) p<0,01
Tail elevation 1.00 (1.00) 0.00 (2.00) p<0,01
Touch scape 2.00 (3.00) 1.00 (1.00) p<0,01
Trunk curl 0.00 (1.00) 1.00 (1.00) p<0,01
Limb grasping 0.00 (1.00) 1.00 (1.00) p<0,05
Limb clasping 0.00 (3.00) 3.00 (3.00) p<0,05
Limb tone 2.00 (2.00) 3.00 (1.00) p<0,01
Negative geotaxis 0.00 (4.00) 3.00 (4.00) p<0,01
Agression 0.00 (1.00) 0.00 (1.00) p<0,05
Vocalization 0.00 (1.00) 1.00 (1.00) p<0,05
Mann-Whitney U-testControl  (n=35) Epilepsy (n=7)
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models of aggression suggest that an imbalance 
in the activation of the central amygdala and 
lateral/ventrolateral periaqueductal gray versus 
that of the septum and dorsolateral periaqueductal 
gray underlie the expression of violent attacks 
under various circumstances (Haller et al. 2006). 
Important to the context of the present study is 
the fact that none of these brain regions has been 
histopathologically characterized in FVB/N mice 
with spontaneous seizures.
Figure 2. Animal observations during SHIRPA protocol revealed that epileptic FVB/N mice presented 
neurological symptoms, such as limb grasping, limb clasping and trunk curling (A) and a reduced pelvic 
elevation (B). Quantitative analysis of the footprint pattern produced by epileptic and control groups at 
52 weeks of age: frontbase width (C) and hindbase width (E). Bars indicate means ± SEM of each group. 
Asterisks indicate statistically significant differences in the performance of normal and epilepsy animals (** 
p<0. 01). (D) Footprinting pattern of control (Ct) and epileptic (Ep) animals.
 Scand. J. Lab. Anim. Sci. 2010 Vol. 37 No. 3
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Basic activity monitoring has been reported to 
be useful for distinguishing seizure-prone from 
control strains mice. For example, in EL mice, a 
natural model of multifactorial idiopathic epilepsy 
(Imaizumi et al. 1959) that has been validated 
through electroencephalographic studies, (Suzuki & 
Nakamoto 1977; Suzuki 1976), it has been shown 
that 40-day-old animals prior to the age of seizure 
Figure 3. Cluster analysis of scores by specific functions, for epilepsy and control groups at 52 weeks of 
age. Bars indicate means ± SEM of each group. Asterisks indicate statistically significant differences in 
performance between normal and epileptic animals (** p<0. 01).
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onset (70-90 days) exhibited spontaneous nocturnal 
locomotor hyperactivity (Drage & Heinrichs 2005). 
In a study with young adult FVB/N mice (12 weeks) 
with no description of seizure occurrence, this strain 
was described to exhibit an abnormal circadian 
behaviour  with a fragmented and arrhythmic 
activity pattern  and increased activity during the 
light phase (Pugh et al. 2004). In contrast, our 
results suggest that FVB/N epilepsy-experienced 
animals present a deficit in spontaneous activity and 
exploratory behaviour during the diurnal period, 
mainly evaluated by the decrease of number of 
squares in the arena and in the number of rears in 
the viewing jar. Although we have not performed 
circadian activity evaluation, our interpretation 
is that this reduction is probably due to the motor 
impairment that these mice manifest.
A variety of seizure-prone mutant mice, including 
ducky, stargazer, “lethargic” and tottering (Meier 
1968; Dung & Swigart 1971; Meier & MacPike 
1971; Noebels et al. 1990), manifest a moderate to 
severe ataxia (Fletcher & Frankel 1999). This is not 
typically observed in human patients with epilepsy, 
with the exception of children with Dravet syndrome 
(or severe myoclonic epilepsy in infancy - SMEI), 
a severe form of generalized epilepsy with febrile 
seizures, who at a later stage manifest absence 
seizures, myoclonic seizures, simple or complex 
partial seizures and ataxia (Claes et al. 2001). 
Our results show that FVB/N mice with recurrent 
epilepsy also manifest gait ataxia, evaluated by the 
significant enlargement of the front-base and hind-
base width. Additionally, these epileptic animals 
present a decrease in muscle strength, higher 
hindlimb tonus and other neurological symptoms 
such as limb grasping, limb clasping, tremors and 
trunk curling, revealing significant deficits both in 
the spinocerebellar function and in the muscle and 
lower motor neuron function. Again, this pattern of 
dysfunction suggests that other brain regions besides 
the hippocampal mossy fiber system (Mineur & 
Crusio 2002) might be affected in FVB/N mice 
with spontaneous seizures. Whether dysfunctions in 
these additional areas in epileptic FVB/N mice are 
the cause, or rather a consequence of the seizures 
themselves is still unknown, but certainly a relevant 
issue to address in future studies.
The knowledge of murine susceptibility genes for 
seizure-induced cell death could be useful for the 
rapid identification of key molecular targets for 
neuroprotective drug design. We propose that the 
FVB/N mouse strain could be of great importance 
in the identification of such genes, and for that 
reason it is important to further characterize the 
neurological and neuropathological phenotype 
and the natural history of epilepsy in this mouse 
strain. Our results suggest that in addition to 
neuropathological lesions in the cerebral cortex, 
hippocampus and thalamus previously described 
in this model, other brain regions must be severely 
affected in this animal model (Goelz et al. 1998), 
probably as a consequence of seizure experience. 
The detailed analysis of this animal model could 
contribute to clarify the manner in which seizure-
induced lesions may cause secondary neurological 
and behavioural alterations in persistent epilepsy.
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